Tune in for key findings in the Swedish Drug Discovery and Development Pipeline Report 2023. We mark the release of the report by a live broadcast, Wednesday March 8th at 14.00, from the studio of our member and launch partner, DNB. You are welcome to submit questions during the broadcast.
The report can be found online and in print from March 8th. It contains a mapping of the pharmaceutical pipeline run by companies headquartered in Sweden. We present an overview and analyzes of both the companies and the pharmaceutical projects, with an extra focus on international comparisons and development over time.
The target group for the report includes international investors, the life science industry in Sweden and of course decision makers within politics, business and academia. The aim of the report is to be a basis for fact-based improvements of the industry and to promote Sweden’s position in pharmaceutical development.
Sign up here for the live broadcast.
